tiprankstipranks
Adaptive Biotechnologies Corp (ADPT)
NASDAQ:ADPT
US Market

Adaptive Biotechnologies (ADPT) Financial Statements

Compare
897 Followers

Adaptive Biotechnologies Financial Overview

Adaptive Biotechnologies's market cap is currently $1.22B. The company's EPS TTM is $-1.085; its P/E ratio is ―; Adaptive Biotechnologies is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 178.96M$ 170.28M$ 185.31M$ 154.34M$ 98.38M
Gross Profit$ 106.88M$ 94.72M$ 127.40M$ 105.04M$ 75.85M
Operating Income$ -162.55M$ -227.03M$ -200.19M$ -208.97M$ -152.82M
EBITDA$ -128.76M$ -189.27M$ -167.98M$ -193.34M$ -144.34M
Net Income$ -159.49M$ -225.25M$ -142.46M$ -205.61M$ -139.64M
Balance Sheet
Cash & Short-Term Investments$ 222.29M$ 346.40M$ 498.20M$ 353.06M$ 688.27M
Total Assets$ 539.38M$ 661.13M$ 856.62M$ 923.34M$ 1.12B
Total Debt$ 89.39M$ 229.43M$ 108.00M$ 111.74M$ 107.86M
Net Debt$ 41.47M$ 164.37M$ 17.97M$ -27.32M$ -15.57M
Total Liabilities$ 336.89M$ 352.86M$ 392.52M$ 319.24M$ 373.15M
Stockholders' Equity$ 202.71M$ 308.40M$ 464.17M$ 603.99M$ 743.27M
Cash Flow
Free Cash Flow$ -98.88M$ -167.02M$ -200.29M$ -254.47M$ -168.49M
Operating Cash Flow$ -95.21M$ -156.32M$ -183.94M$ -192.73M$ -149.68M
Investing Cash Flow$ 77.79M$ 129.65M$ 2.90M$ 181.21M$ -117.04M
Financing Cash Flow$ 241.00K$ 2.25M$ 132.26M$ 27.15M$ 293.59M
Currency in USD

Adaptive Biotechnologies Earnings and Revenue History

Adaptive Biotechnologies Debt to Assets

Adaptive Biotechnologies Cash Flow

Adaptive Biotechnologies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis